280 related articles for article (PubMed ID: 21771891)
1. Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency.
Chen M; Mema E; Kelleher J; Nemechek N; Berger A; Wang J; Xie T; Gavrilova O; Drucker DJ; Weinstein LS
Endocrinology; 2011 Sep; 152(9):3343-50. PubMed ID: 21771891
[TBL] [Abstract][Full Text] [Related]
2. Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency.
Chen M; Gavrilova O; Zhao WQ; Nguyen A; Lorenzo J; Shen L; Nackers L; Pack S; Jou W; Weinstein LS
J Clin Invest; 2005 Nov; 115(11):3217-27. PubMed ID: 16239968
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
[TBL] [Abstract][Full Text] [Related]
4. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
5. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
6. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
[TBL] [Abstract][Full Text] [Related]
7. Pancreas-specific Gsalpha deficiency has divergent effects on pancreatic alpha- and beta-cell proliferation.
Xie T; Chen M; Weinstein LS
J Endocrinol; 2010 Sep; 206(3):261-9. PubMed ID: 20543009
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
9. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
[TBL] [Abstract][Full Text] [Related]
10. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
Flamez D; Gilon P; Moens K; Van Breusegem A; Delmeire D; Scrocchi LA; Henquin JC; Drucker DJ; Schuit F
Diabetes; 1999 Oct; 48(10):1979-86. PubMed ID: 10512362
[TBL] [Abstract][Full Text] [Related]
11. Alterations in pancreatic islet cell function in response to small bowel resection.
Courtney CM; Shyr ZA; Yan Z; Onufer EJ; Steinberger AE; Tecos ME; Barron LK; Guo J; Remedi MS; Warner BW
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G36-G42. PubMed ID: 32463335
[TBL] [Abstract][Full Text] [Related]
12. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
[TBL] [Abstract][Full Text] [Related]
13. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
16. Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice.
Clemmensen C; Smajilovic S; Smith EP; Woods SC; Bräuner-Osborne H; Seeley RJ; D'Alessio DA; Ryan KK
Endocrinology; 2013 Nov; 154(11):3978-83. PubMed ID: 23959939
[TBL] [Abstract][Full Text] [Related]
17. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
18. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
[TBL] [Abstract][Full Text] [Related]
19. The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones.
Rudenko O; Shang J; Munk A; Ekberg JP; Petersen N; Engelstoft MS; Egerod KL; Hjorth SA; Wu M; Feng Y; Zhou YP; Mokrosinski J; Thams P; Reimann F; Gribble F; Rehfeld JF; Holst JJ; Treebak JT; Howard AD; Schwartz TW
Mol Metab; 2019 Jan; 19():49-64. PubMed ID: 30472415
[TBL] [Abstract][Full Text] [Related]
20. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
